Novartis Opens Carlsbad Radioligand Therapy Manufacturing Site as Part of $23B US Investment Plan

Carlsbad location is company’s third US-based radioligand therapy (RLT) manufacturing site New site expands manufacturing footprint to meet fut...

November 11, 2025 | Tuesday | News
Merck Presents Phase 3 Data Showing Enlicitide Achieved Up to 60% LDL-C Reduction With Placebo-Like Safety

Enlicitide, designed to deliver antibody-like efficacy, has the potential to be the first approved oral PCSK9 inhibitor to lower LDL-C with a safety pr...

November 10, 2025 | Monday | Reports
Rapid Micro Biosystems CEO Robert Spignesi Highlights Strong Q3 Execution and Record Consumable Revenue

Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter 2025 recu...

November 10, 2025 | Monday | Company results
Cytiva Launches Fibro dT Platform to Accelerate High-Yield mRNA Purification

Fibro dT platform offers a high-capacity solution for mRNA purification with chromatography cycle times under 15 minutes.  Sustainable pe...

November 07, 2025 | Friday | News
Facet Life Sciences and XCancer Form Strategic Partnership to Accelerate Development of Theranostic Radiopharmaceuticals

Facet Life Sciences, a leader in regulatory strategy and drug development services, announced a strategic partnership with XCancer®, a global leader ...

November 07, 2025 | Friday | News
Alvotech and Advanz Pharma Receive UK Marketing Authorisations for Gobivaz®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

November 07, 2025 | Friday | News
Abzena and Mabqi Announce Strategic Partnership to Deliver End-to-End Antibody Discovery and Development

Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on the discovery and d...

November 07, 2025 | Friday | News
Dispatch Bio and Bristol Myers Squibb Announce Clinical Supply Agreement for Ide-Cel to Support DISP-10 Development

Bristol Myers Squibb to provide idecabtagene vicleucel (ide-cel) for Dispatch’s planned U.S. Phase 1 study, expected to initiate in 2026 Collabo...

November 05, 2025 | Wednesday | News
Enara Bio Expands EDAPT Platform to Include Dark Cell Surface Proteins

  Enara’s discovery of DARKFOX delivers on the vision of translating the dark genome into a new class of clinically actionable Dark Antigens ...

November 05, 2025 | Wednesday | News
Sartorius And Aber Instruments Extend BioPAT® Viamass Integration To Ambr® 250 Advancing Real-Time Biomass Monitoring Across Scales

BioPAT® Viamass provides high resolution real-time viable capacitance-based biomass measurement directly in the cell culture, enabling direct inlin...

November 04, 2025 | Tuesday | News
CARsgen Reports Promising Early Clinical Data for Allogeneic CAR-T Candidates CT0596 and CT1190B in Multiple Myeloma and Lymphoma

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for...

November 04, 2025 | Tuesday | Reports
Sanyou Biopharmaceuticals and Shanghai ZJ Bio-Tech Forge Strategic Partnership to Automate Innovative Biologics Development

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter refer...

November 04, 2025 | Tuesday | News
INOVIO Completes BLA Submission for INO-3107, a DNA Immunotherapy for Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously rece...

November 04, 2025 | Tuesday | News
Virax Biolabs Completes Full UK Recruitment for ViraxImmune™ Clinical Study on Long COVID and Related Syndromes

Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses t...

November 04, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close